Endpoints News – Biotech, drug, pharma and health news for …
WEBCash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution. The US could upend biopharma manufacturing. WuXi rivals have an opening. Star ...
Big dreams dominate among next-gen biotech players
WEBHere’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group. sponsored by. see the winners.
Endpoints Careers - Find your next biopharma job
WEBNew benefit for Enterprise subscribers. All companies with an Enterprise subscription to Endpoints News will now receive two spotlight job postings per year at no charge.Contact your company subscriptions manager or DeAna (cs-advertising@endpointsnews.com) for more information.. For sales inquires or package requests, connect with Meg at mestacio@endpointsnews.com.
Endpoints 11 | Biopharma's Most Promising Startups in 2021
WEBThe biotech 2.0 era has arrived. And with that backdrop, we'll unveil the top 11 companies supercharging a new generation of startups in 2021. Watch John Carroll & John Chiminski as they talk biotech with the teams behind the winning companies and learn what defines the Endpoints 11.
Profluent debuts to design proteins with machine learning in bid …
WEBJan 26, 2023 · While OpenAI’s Microsoft-allied ChatGPT takes the world by storm, a fledgling startup in Berkeley, CA is debuting to take a similar language-learning model ap ...
Leading healthcare agency notches double-digit growth for first …
WEBSep 2, 2022 · While the ad industry is navigating a jittery economy — and the looming threat of marketing budget cuts — the pharma sector seems to be humming along …
Ex-MD Anderson chief DePinho is helping launch another biotech …
WEBJan 27, 2021 · Years after co-founding SINE-focused Karyopharm and stirring up controversy at MD Anderson, Ronald DePinho is helping uncloak a new biotech targeting solute carri ...
Takeda hops onto $61M round for CRISPR player synthesizing …
WEBJan 15, 2020 · Amber Tong. Senior Editor. Takeda Ventures and OrbiMed have helped pump $61 million into a New York biotech joining the rush to dramatically expand the CRISPR tool kit. ….
News – Endpoints News
WEBTo tackle a deadly brain disease, scientists devise small but charming epigenetic editing tool. Grail pioneered multi-cancer tests. But the company’s rough pub ...
Fore scores $75M Series D, tees up new leadership with ex …
WEBAug 23, 2023 · Fore Biotherapeutics has reeled in a $75 million Series D, and its CEO Matthew Ros is walking off the course for “other professional pursuits,” the …
Skip to content